Results 21 to 30 of about 4,105,314 (99)

Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC [PDF]

open access: yes, 2021
BACKGROUND: Peritoneal metastasis from pancreatic cancer (PM-PC) may be treated with repeated pressurised intraperitoneal aerosol chemotherapy (PIPAC). Utility of next-generation sequencing (NGS) to detect cancer-related mutations in peritoneal quadrant ...
Kristensen, Thomas Kielsgaard   +7 more
core   +1 more source

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients [PDF]

open access: yes, 2020
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) represents a novel approach to intraperitoneal chemotherapy. Hereby results, obtained with PIPAC in patients with advanced peritoneal metastasis (PM) from colorectal cancer (CRC), are presented ...
Lundell, L,   +13 more
core   +1 more source

UEG Week 2023 Moderated Posters

open access: yes, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 201-534, October 2023.
wiley   +1 more source

UEG Week 2023 Poster Presentations

open access: yes, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley   +1 more source

Abstract

open access: yes, 2022
Research and Practice in Thrombosis and Haemostasis, Volume 6, Issue S1, October 2022.
wiley   +1 more source

Importância da resposta histológica tumoral à quimioterapia preoperatória na predição do outcome de doentes com carcinomatose peritoneal por carcinoma colorretal, tratados com cirurgia de citorredução seguida de HIPEC

open access: yes, 2022
Introdução: Até um quarto dos pacientes com carcinoma colorretal desenvolvem carcinomatose peritoneal. Em doentes selecionados, o tratamento de eleição passa por cirurgia de citorredução e quimioterapia intraperitoneal hipertérmica.
Isa Valéria Ferreira de Sousa
core   +1 more source

Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy:Results from the Prospective PIPAC-OPC2 Study

open access: yes, 2023
BACKGROUND: Pressurized Intraperitoneal Aerosol chemotherapy (PIPAC) is a local treatment for peritoneal metastasis (PM). Prospective data are scarce and evaluation of treatment response remains difficult.
Detlefsen, S; id_orcid   +7 more
core   +1 more source

Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases

open access: yes, 2022
Background The aim of this study was to analyse survival and surrogates for oncological response after PIPAC for appendiceal tumours. Methods This retrospective cohort study included consecutive patients with appendiceal peritoneal metastases (PM ...
SP Somashekhar   +24 more
core   +1 more source

Second annual report from the ISSPP PIPAC database [PDF]

open access: yes, 2023
OBJECTIVES: To monitor the results of PIPAC directed therapy based on data from the International Society for the Study of the Pleura and Peritoneum (ISSPP) PIPAC database.METHODS: Analysis of data from patients entered between June 15th, 2020, and ...
Jørgensen, Magnus Skov   +25 more
core   +1 more source

Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases

open access: yesJournal of Surgical Oncology, Volume 130, Issue 6, Page 1422-1432, November 2024.
Abstract Treatment guidelines provided by PRODIGE‐7 recommend perioperative systemic chemotherapy before cytoreductive surgery (CRS) for colorectal cancer peritoneal metastases (CRPM). Toxicity with multimodal treatment needs to be better defined. Chemotherapy response and impact on survival have not been reported.
Nadina Tinsley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy